BioReliance

February 4, 2019

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

June 14, 2017

The Future of BioManufacturing: Modular Factories & End-to-End Solutions

November 6, 2014

BioReliance Introduce Advanced In Vitro ADME and Toxicology Services

BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services […]
Contact Us